New Evidence Available

Updated Recommendation

A new evidence synthesis was published:2025, WHO consolidated guidelines on tuberculosis: module 3: diagnosis

View latest version (2025)

Bibliographic information

GuidelineWHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 3rd ed.
Year of Publication2024
Issuing InstitutionWorld Health Organization

Recommendation

Retired

In adults and children with signs and symptoms of extrapulmonary TB, Xpert MTB/RIF may be used in lymph node aspirate, lymph node biopsy, pleural fluid, peritoneal fluid, pericardial fluid, synovial fluid or urine specimens as the initial diagnostic test rather than smear microscopy/culture.

Recommended in favor

Conditional

Notes and Remarks

Remarks Clinical judgement and pretest probability should guide treatment. In a high pretest probability setting (>5%), a negative test result will not rule out the condition. Available data on Xpert MTB/RIF for children have included lymph node aspirate and lymph node biopsy specimens; given the similarity of the effects, the recommendation for adults is extrapolated for children.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

WHO consolidated guidelines on tuberculosis: module 3: diagnosis – rapid diagnostics for tuberculosis detection: web annex 2. GRADE profiles

Year2020
InstitutionWHO
Guideline

WHO consolidated guidelines on tuberculosis: module 3: diagnosis – rapid diagnostics for tuberculosis detection: web annex 2. GRADE profiles

Year2020
InstitutionWHO